Surgical interventions in multidrug-resistant tuberculosis: Retrospective analysis of 27 patients treated at a tertiary level care center

Pakistan Journal of Medical Sciences

Volumn 24, Issue 3, 2008, Pages 351-355

  Bilal, Amer ^a   Baseer, Abdul ^a   Muslim, Mohammad ^a   Faridullah, ^a   Javaid, Arshad ^b   Afridi, M Z ^b   Khan, M Y ^b  

^a LADY READING HOSPITAL   (Pakistan)

^b PGMI ^*  (Pakistan)

Author keywords

Multidrug resistant tuberculosis; Pulmonary resection; Thoracoplasty

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRONCHOPLEURAL FISTULA; CLINICAL ARTICLE; CONTROLLED STUDY; EMPYEMA; FEMALE; FOLLOW UP; HUMAN; LOBECTOMY; LUNG RESECTION; MALE; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PAKISTAN; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRESCRIPTION; RETROSPECTIVE STUDY; SPUTUM ANALYSIS; SURGICAL MORTALITY; SURGICAL WARD; TERTIARY HEALTH CARE; THORAX SURGERY; TUBERCULOSIS;

EID: 46749093399     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Alexander J. The Collapse therapy of Tuberculosis Springfield: Charles C Thomas 1937.
2. Espinal MA, Simonsen L, Laszlo A, Boulahbal F, Kim SJ, Reneiro A, et al. For the WHO/International Union Against Tuberculosis and Lung Disease Global Working Group on Anti-tuberculosis Drug Resistance Surveillance. Anti- tuberculosis drug resistance in the world. Report No. 2. Geneva: World Health Organization; 2000. Unpublished document WHO/TB/2000.278. Available from: URL: [www.who.int/gtb/publications/dru].
3. Pablos-Mendez A, Gowda DK, Frieden TR. Controlling multidrug-resistant tuberculosis and access to expensive drugs: A rational framework. Bull World Health Organ. 2002;80:489-95; discussion 495-500.
4. WHO Report 2002.Global Tuberculosis Control: Surveillance, Planning, Financing WHO/CDS/TB/2002.295.
5. World Health Organization. WHO report on the tuberculosis epidemic, 1997 Geneva: WHO 1997.
6. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. For the WHO Global Surveillance and Monitoring Project. Global burden of tuberculosis. Estimated incidence, prevalence and mortality by country. JAMA 1999;282:677-86.
7. WHO Global DOTS expansion plan, program in the TB control in high burden countries, WHO/CDS/2001.
8. Loddenkemper R, Sugebiel D, Brendel A. Stategies against multidrug resistant tuberculosis. Eur Respir J 2002;20:66S-77S.
9. MDR-TB Fact sheet, American Lung Association, March 2005.
10. Pomerantz M, Maden L, Goble M, Isemen M. Surgical intervention in the treatment of pulmonary disease caused by drug resistant mycobacterium tuberculosis. Am Rev Respir Dis 1990;141:623-5.
11. Albino JA, Reichman LB. The treatment of Tuberculosis. Respiration 1998;65:237-55.
12. Pomrantz BJ, Cleaveland JC, Olson HK, Pomerantz M. Pulmonary resection for MDR-TB. J Thoracic Cardiovasc Surg 2001;121:448-53.
13. Takeda S, Maeda H, Hayakawa M, Sawabata N, Maekura R. Current surgical intervention for multidrug resistant tuberculosis. Ann Thorac Surg 2005;79:959-63.
14. Shiraishi Y, Nkajima Y, Katsuragi N, Kurai M, Takahashi N. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug resistant tuberculosis. J Thorac Cardiovasc Surg 2004;128:523-8.
15. Leuvan MV, Groot MD, Sheen KP, Von-oppell UO, Willcox PA. Pulmonary resection as an adjunct in the treatment of multidrug resistant tuberculosis. Ann Thorac Surg 1997;63:1368-72.
16. Parek SK, Lee CM, Heu JP, Song SD. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug resistant tuberculosis. Int J Tuberc Lung Dis 2002;6:143-9.